CA145831-01/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2014	1
2015	2
2025	0

Page 1

Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact response.

Duong VH, Baer MR, Hendrick F, Weiss SR, Sato M, Zeidan AM, Gore SD, Davidoff AJ. Duong VH, et al. Leuk Res. 2015 Jun;39(6):586-91. doi: 10.1016/j.leukres.2015.03.013. Epub 2015 Mar 28. Leuk Res. 2015. PMID: 25869077 Free PMC article.

Patient cost sharing and receipt of erythropoiesis-stimulating agents through medicare part D.

Davidoff AJ, Hendrick FB, Zeidan AM, Baer MR, Stuart BC, Shenolikar RA, Gore SD. Davidoff AJ, et al. J Oncol Pract. 2015 Mar;11(2):e190-8. doi: 10.1200/JOP.2014.001527. Epub 2015 Jan 6. J Oncol Pract. 2015. PMID: 25563701 Free PMC article.

Effect of erythropoiesis-stimulating agent policy decisions on off-label use in myelodysplastic syndromes.

Hendrick F, Davidoff AJ, Zeidan AM, Gore SD, Baer MR. Hendrick F, et al. Medicare Medicaid Res Rev. 2014 Nov 26;4(4):mmrr2014-004-04-a02. doi: 10.5600/mmrr.004.04.a02. eCollection 2014. Medicare Medicaid Res Rev. 2014. PMID: 25485173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year